To Win Monopoly Fight, Meta Is Touting a Rival: TikTok 
 

If a judge decides the video app competes in the same space as Facebook and Instagram, it could sink FTC's bid to break up the social-media giant.

 
Gold Fields to Buy Australia's Gold Road for Roughly $2.4 Billion 
 

Australia's Gold Road Resources agreed to a sweetened $2.4 billion takeover by South Africa's Gold Fields, after rejecting an earlier bid against a backdrop of surging gold prices.

 
Trump's Tariffs Are Lifting Some U.S. Manufacturers 
 

Levies on imports are giving early boosts to some American factories.

 
What a $15,000 Electric SUV Says About U.S.-China Car Rivalry 
 

For an American used to a $50,000 gasoline-powered SUV as the standard family choice, the Chinese market is hardly recognizable.

 
Warren Buffett Plans to Step Down as Berkshire CEO at Year-End 
 

Speaking at Berkshire's annual meeting in Omaha, Buffett Says Greg Abel Should Succeed at Year-End.

 
Car Buyers Rushing to Beat Tariffs Find It's Tougher to Get Financing 
 

Auto lenders tightened lending in recent years after the pandemic car-buying frenzy.

 
Disney Wanted More From Marvel. Now It Wants Less. 
 

The superhero studio is cutting back TV production and fixing its film slate.

 
These Electric Motors Could Help Break the World's Dependence on China 
 

Conifer motors is making a low-cost power plant for everything from scooters to factories

 
United Airlines Cancels Newark Flights Over FAA Staffing 
 

United has been urging the government to limit the number of flights to what an airport can realistically manage based on staffing, CEO Scott Kirby said.

 
Novo Nordisk Says FDA Accepted New Drug Application for Wegovy Pill 
 

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a GLP-1 drug for chronic weight management.

(END) Dow Jones Newswires

May 04, 2025 21:00 ET (01:00 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.